Hypera (OTCMKTS:HYPMY) Stock Passes Above Fifty Day Moving Average of $7.58
Hypera (OTCMKTS:HYPMY) Stock Passes Above Fifty Day Moving Average of $7.58
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.58 and traded as high as $8.14. Hypera shares last traded at $8.12, with a volume of 2,876 shares traded.
Hypera Price Performance
The company has a market cap of $5.23 billion, a PE ratio of 19.33 and a beta of 0.82. The company has a fifty day moving average price of $7.58 and a 200 day moving average price of $7.25.
About Hypera
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Articles
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.58 and traded as high as $8.14. Hypera shares last traded at $8.12, with a volume of 2,876 shares traded.
Hypera S.A.(場外交易代碼:HYPMY-GET Rating)在週四的交易中突破了50日移動均線。該股的50日移動均線為7.58美元,最高交易價格為8.14美元。Hypera股價最新報8.12美元,總成交量為2,876股。
Hypera Price Performance
Hypera性價比
The company has a market cap of $5.23 billion, a PE ratio of 19.33 and a beta of 0.82. The company has a fifty day moving average price of $7.58 and a 200 day moving average price of $7.25.
該公司市值為52.3億美元,市盈率為19.33倍,貝塔係數為0.82。該公司的50日移動平均價為7.58美元,200日移動平均價為7.25美元。
About Hypera
關於Hypera
(Get Rating)
(獲取評級)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作為一家制藥公司運營。它提供的處方藥有Adacne、Addera、Apri、AmpliumG、請、賽萊他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、雙丙胺、雙丙沙星、雙丙鬆、雙丙鬆、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混懸劑、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- 免費獲取StockNews.com關於Hypera的研究報告(HYPMY)
- MarketBeat:回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升,是時候收購了嗎?
- 蘋果為何可能在年底創下歷史新高
- Beyond Meat不是沒有希望,而且它很便宜
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Hypera和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧